No, skin cancer itself does not produce pus. Pus is a byproduct of the immune system fighting bacteria, made of dead neutrophils, tissue debris, and fluid. Cancer cells do not generate pus on their own. But a cancerous lesion can become infected, and an infected tumor will produce pus. That distinction matters because it changes what you are looking at and when to act.
The confusion is understandable. Basal cell carcinoma, the most common skin cancer, often develops a crusted center that looks like a pimple that will not heal. Squamous cell carcinoma can ulcerate and drain. Both get mistaken for infections by patients and, occasionally, by clinicians. The question is not whether cancer makes pus. The question is whether a pus-producing sore could be cancer hiding underneath.
The mechanism of pus formation
Pus forms when neutrophils, a type of white blood cell, migrate to a site of bacterial invasion and die there. The resulting mixture of dead cells, liquefied tissue, and plasma is what you see. This process requires bacteria or another foreign trigger. Cancer cells do not recruit neutrophils in the same way, and a clean tumor does not generate pus.
Skin cancers grow by uncontrolled proliferation of keratinocytes or melanocytes. They damage surrounding tissue through invasion and angiogenesis, the growth of new blood vessels to feed the tumor. That vessel growth can be fragile and leaky. Tumors can outgrow their blood supply and die in patches, creating necrosis. Necrotic tissue can break down and drain, but what drains is serous fluid or blood, not pus.
When a tumor ulcerates, it breaches the skin barrier. That breach is the opening bacteria need. An ulcerated basal cell or squamous cell carcinoma can become colonized or infected, and at that point pus appears. The pus is a sign of infection on top of cancer, not a product of the cancer itself.
This distinction is more than semantic. If you treat an infected lesion with antibiotics and the infection clears but the lesion persists, you have not solved the problem. You have unmasked it.
How common is infection in skin cancer
Quantifying this is harder than it sounds because studies vary by cancer type, location, and patient population. What is clear from clinical literature is that infection is a recognized complication of ulcerated skin tumors, particularly squamous cell carcinoma and tumors on the head and neck where bacterial colonization is heavy.
Basal cell carcinoma is the most common skin cancer in the United States, with an estimated 3.6 million cases diagnosed annually. Squamous cell carcinoma adds roughly 1.8 million cases. Most of these lesions never become infected. The ones that do tend to be larger, longer-standing, or located where hygiene is difficult or where the tumor has already ulcerated deeply.
The practical takeaway: infection is an uncommon but real complication. A skin cancer that produces pus is usually a cancer that has been present long enough to ulcerate. That is a reason to seek evaluation, not a reason to assume the problem is minor.
Timeline: from lesion to pus
Use this table to understand how a skin cancer can progress from a subtle spot to an infected, draining wound. The timeline is illustrative and varies widely by tumor type and host factors.
| Stage | Approximate time frame | What happens | Pus present? |
|---|---|---|---|
| Early lesion | Weeks to months | Small, pearly, or scaly spot; no breakdown | No |
| Growth phase | Months | Tumor enlarges, vessels proliferate, surface thins | No |
| Ulceration | Months to years | Skin barrier breaks down; crusting and bleeding | No, unless colonized |
| Colonization | Days to weeks after ulceration | Bacteria colonize the wound surface | Possible |
| Clinical infection | Variable | Redness, warmth, swelling, purulent drainage | Yes |
| Chronic wound | Months | Non-healing ulcer with intermittent drainage | Intermittent |
The gap between ulceration and infection is what makes this dangerous. A patient may watch a sore for months, treating it with antibiotic ointment, assuming it is a stubborn infection. The underlying cancer continues to grow.
Edge cases and counterintuitive findings
Keratoacanthoma is a tumor that looks like a volcano. It grows rapidly over weeks, develops a central keratin plug, and can drain material that resembles pus. That material is keratin and debris, not neutrophil-rich pus. Keratoacanthomas can regress spontaneously, which adds to the confusion. Some pathologists classify them as a variant of squamous cell carcinoma. Either way, the drainage is not pus.
Another edge case: a skin cancer can obstruct a hair follicle or sebaceous gland, causing a cyst or abscess nearby. The pus comes from the blocked gland, not the tumor. The two conditions coexist. A clinician who drains the abscess and moves on may miss the tumor.
The counterintuitive point is this. A lesion that produces pus is more likely to be benign than malignant. Abscesses, folliculitis, and hidradenitis suppurativa are common. Skin cancer is less common. But the base rate does not tell you what is happening in one patient. A non-healing, pus-producing lesion in a sun-damaged area deserves a biopsy, regardless of base rates.
The professional caveat: dermatologists are trained to biopsy lesions that do not heal within four to six weeks, even if they look infectious. A course of antibiotics that clears the pus but not the lesion is a red flag, not a resolution.
Red-flag warning signs
Seek prompt evaluation if you notice any of the following:
A sore that drains pus and has not healed after two to three weeks of wound care A lesion that bleeds easily, crusts, and recurs in the same spot A pearly or translucent bump with visible blood vessels A rough, scaly patch that persists despite moisturizer or antifungal treatment A mole that changes color, shape, or size, or develops a draining center
These signs do not confirm cancer. They confirm that the lesion needs a professional look.
Skin cancer versus other pus-producing lesions
This table compares common causes of pus-producing skin lesions. It is not a diagnostic tool. It is a framework for understanding why visual inspection alone is unreliable.
| Condition | Typical appearance | Pus? | Key distinguishing feature |
|---|---|---|---|
| Basal cell carcinoma | Pearly bump, rolled edge, telangiectasias | Rare, unless ulcerated and infected | Slow growth, sun-exposed skin |
| Squamous cell carcinoma | Rough, scaly, ulcerated plaque | Possible if infected | Faster growth, tenderness |
| Keratoacanthoma | Dome with central keratin plug | Keratinous drainage, not true pus | Rapid growth over weeks |
| Bacterial abscess | Red, warm, fluctuant nodule | Yes, frank pus | Pain, fever, rapid onset |
| Folliculitis | Small pink papules or pustules | Yes, superficial | Hair-bearing areas |
| Hidradenitis suppurativa | Nodules, tracts, scarring | Yes, recurrent | Axillae, groin, chronic course |
The table shows overlap. A basal cell carcinoma with a crusted center can look like folliculitis. A squamous cell carcinoma with purulent drainage can look like an abscess. The only way to separate them is histology, which means biopsy.
Practical actions and thresholds
If you have a lesion that concerns you, act on these concrete steps.
First, measure the lesion. Note the size in millimeters and whether it has changed over four weeks. A lesion that grows is more concerning than one that is stable.
Second, track healing. Minor wounds heal within two to three weeks. A lesion that persists beyond four weeks, with or without pus, warrants evaluation.
Third, do not treat and wait indefinitely. Over-the-counter antibiotic ointment is reasonable for a suspected minor infection. If the lesion does not clear within seven to ten days of consistent use, stop treating and see a clinician.
Fourth, ask for a biopsy if the lesion is biopsied and the result is ambiguous. A shave biopsy may not capture the base of a tumor. An excisional or punch biopsy is more reliable for suspected malignancy.
Fifth, photograph the lesion weekly. Change is easier to detect in serial images than in memory.
Sixth, protect the area from sun exposure while awaiting evaluation. Ultraviolet radiation drives further mutation.
If you have a history of skin cancer, immunosuppression, or extensive sun exposure, lower your threshold for evaluation. These factors increase both cancer risk and the chance that a lesion will behave atypically.
Limitations and what this does not cover
This explainer describes mechanisms and general patterns. It does not diagnose. A lesion that produces pus may be cancer, an infection, or both. Only a clinician with a biopsy can tell you which.
The evidence on infection rates in skin cancer is limited by heterogeneous study designs and inconsistent definitions of infection. Many case series do not report infection as an outcome. The numbers cited here come from general incidence data, not from a single study of infected tumors.
Nor does this cover treatment. Treatment decisions depend on tumor type, stage, location, and patient factors. Those decisions belong to a qualified clinician.
What you can take away is this. Pus is a sign of infection, not a product of cancer. But a cancer that has ulcerated can become infected. A non-healing, draining lesion is a reason to seek care, not a reason to assume the problem is minor.